Patents In The Psychedelics Space: Good Or Bad? It’s Complicated, Here’s What The Experts Say
Patents are the golden eggs of the booming psychedelic space.
Gavin Newsom’s Cannabis Tax-Cut Proposal: Industry Leaders Complain It Doesn’t Fix Key Problems
Although California Governor Gavin Newsom’s proposal of eliminating cannabis cultivation taxes has received a lot of support, it also has its detractors.
Awakn’s Study On Psychedelics For Treating Addiction Shows Promise, Will Undertake Broader Research
Awakn Life Sciences (OTCQB: AWKNF) has announced the successful completion of the first ketamine study for a varied set of behavioral addictions.
MindMed Reports Promising Results For Non-Hallucinogenic Ibogaine Congener Substance
MindMed Inc. (NASDAQ: MNMD) reported favorable results for one of its proprietary compounds.
Novamind To Offer Ketamine Treatment To Frontline Workers Who Suffer Pandemic-Related Distress
After a period of clinical pilot, Novamind Inc. (OTCQB: NVMDF) will offer Frontline KAP, group-based ketamine-assisted psychotherapy or KAP, for frontline workers, at some of its clinics.
Psychedelics Retreats Coming To Canada Could Soon Offer Psilocybin Treatment
The investment issuer Origin Therapeutics Holdings announced that one of its companies will offer its first psychedelic retreat. The service will be offered by one of its portfolio companies, Dimensions Health Centres Inc. North of Toronto, Dimensions Algonquin Highlands will host group retreats starting this July.
Numinus Granted Canada’s Special Access Program For Magic Mushrooms To Treat Life-Threatening Conditions
Numinus Wellness Inc (OTCQB: NUMIF) has been approved to use psilocybin-assisted therapy through Health Canada’s Special Access Program (SAP), marking the first instance in which Numinus will provide this treatment outside of a clinical trial.
Red Light Holland Sends Magic Mushrooms Into Canada To Be Used As Pharmaceutical Ingredients
Red Light Holland (OTCPK:TRUFF) has announced the successful export of psilocybin truffles to its partner in Canada, CCrest Laboratories, through a permit given by Health Canada.
MindMed Reports Financial Results For Q1, With Lower Cash Balance Compared To December Last Year
MindMed (NASDAQ: MNMD) announced its financial results for the first quarter of 2022, which ended March 31.
Beckley Retreats Launches To Offer Magic Mushroom Retreats In Jamaica
Following Silo Wellness’ (OTCQB: SILFF) steps, the newly launched Beckley Retreats